- Price
- $1.10
- Day
- +0.92%
- Mkt Cap
- $84.78M
- 52W Range
- $0.76 – $3.31
- Volume
- 703.1K
- Beta
- 1.46
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
SAN DIEGO, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that Mani Mohindru, Ph.D. will participate in two upcoming conferences.
Read full article